INIPOMP Side Effects

7003186-8 | Acute Respiratory Distress Syndrome, Allergic Granulomatous Angiitis, Axonal Neuropathy, Blood Creatine Phosphokinase Increased, Bronchial Disorder, Bronchial Obstruction, Bronchopulmonary Aspergillosis Allergic, Condition Aggravated, Dyspnoea
on Sep 08, 2010 Female patient from GERMANY , weighting 130.1 lb, was diagnosed with gastric ulcer, hypercholesterolaemia, osteoporosis (What is osteoporosis?), temporal arteritis and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, allergic granulomatous angiitis, axonal neuropathy, blood creatine phosphokinase increased, bronchial disorder, bronchial obstruction, bronchopulmonary aspergillosis allergic, condition aggravated, dyspnoea. Inipomp dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PROTELOS (View Protelos Review and Protelos Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), PREDNISONE (5 Mg) (View Prednisone Review and Prednisone Label ), DIFFU K (2 Dosage Forms) (View Diffu K Review and Diffu K Label ), VERAPAMIL (120, 2 Dosage Forms) (View Verapamil Review and Verapamil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6781583-3 | Axonal Neuropathy, Blood Creatine Phosphokinase Increased, Bronchial Disorder, Bronchial Obstruction, Condition Aggravated, Dyspnoea, Hypogammaglobulinaemia, Inflammation
Patient was taking Inipomp (View Usage). Patient had the following side effects: axonal neuropathy, blood creatine phosphokinase increased, bronchial disorder, bronchial obstruction, condition aggravated, dyspnoea, hypogammaglobulinaemia, inflammation on Jun 09, 2010 from GERMANY Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with gastric ulcer, hypercholesterolaemia, osteoporosis (What is osteoporosis?), temporal arteritis and. Inipomp dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PROTELOS (View Protelos Review and Protelos Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), PREDNISONE (5 Mg) (View Prednisone Review and Prednisone Label ), DIFFU K (2 Dosage Forms) (View Diffu K Review and Diffu K Label ), VERAPAMIL (120, 2 Dosage Forms) (View Verapamil Review and Verapamil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6768573-1 | Axonal Neuropathy, Blood Creatine Phosphokinase Increased, Bronchial Disorder, Bronchial Obstruction, Condition Aggravated, Hypogammaglobulinaemia, Inflammation, Lipodystrophy Acquired
Adverse event was reported on Jun 02, 2010 by a Female patient taking Inipomp (View Usage) (Dosage: ) was diagnosed with gastric ulcer, hypercholesterolaemia, osteoporosis (What is osteoporosis?), temporal arteritis and. Location: GERMANY , weighting 130.1 lb, After Inipomp was administered, patient had the following side effects: axonal neuropathy, blood creatine phosphokinase increased, bronchial disorder, bronchial obstruction, condition aggravated, hypogammaglobulinaemia, inflammation, lipodystrophy acquired. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PROTELOS (View Protelos Review and Protelos Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), PREDNISONE (5 Mg) (View Prednisone Review and Prednisone Label ), DIFFU K (2 Dosage Forms) (View Diffu K Review and Diffu K Label ), VERAPAMIL (120, 2 Dosage Forms) (View Verapamil Review and Verapamil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6737536-4 | Glomerulonephritis Membranous, Vertigo
on May 03, 2010 Male patient from FRANCE , 46 years of age, was diagnosed with hiatus hernia and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: glomerulonephritis membranous, vertigo. Inipomp dosage: .


6716444-9 | Hypokalaemia, Hyponatraemia
on Apr 27, 2010 Female patient from GERMANY , 81 years of age, was treated with Inipomp (View Usage). Patient had the following side effects: hypokalaemia, hyponatraemia. Inipomp dosage: . During the same period patient was treated with TENORETIC 100 (View Tenoretic 100 Review and Tenoretic 100 Label ), STRUCTUM (View Structum Review and Structum Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), BETASERC (View Betaserc Review and Betaserc Label ), CALTRATE (View Caltrate Review and Caltrate Label ), CRESTOR (View Crestor Review and Crestor Label ), IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), LOGIMAX (View Logimax Review and Logimax Label ). Patient was hospitalized.

6714148-X | Prostate Cancer
Patient was taking Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: prostate cancer (What is prostate cancer?) on Apr 06, 2010 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with abdominal pain upper and. Inipomp dosage: .

6695716-0 | Glomerulonephritis Membranous, Vertigo
Adverse event was reported on Apr 14, 2010 by a Male patient taking Inipomp (View Usage) (Dosage: ) was diagnosed with hiatus hernia and. Location: FRANCE , 46 years of age, Patient experienced the following unwanted or unexpected effects: glomerulonephritis membranous, vertigo.

6657065-6 | Deep Vein Thrombosis, Pleural Effusion, Pulmonary Embolism, Pyrexia, Tuberculosis
on Mar 26, 2010 Female patient from FRANCE , 84 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Inipomp (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pleural effusion, pulmonary embolism (What is pulmonary embolism?), pyrexia, tuberculosis (What is tuberculosis?). Inipomp dosage: . During the same period patient was treated with PROTELOS (View Protelos Review and Protelos Label ), METOJECT (View Metoject Review and Metoject Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), IXPRIM (View Ixprim Review and Ixprim Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), IPERTEN (10 Mg) (View Iperten Review and Iperten Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6641810-X | Deep Vein Thrombosis, Pleural Effusion, Pulmonary Embolism, Pyrexia, Tuberculosis
on Mar 08, 2010 Female patient from FRANCE , 84 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pleural effusion, pulmonary embolism (What is pulmonary embolism?), pyrexia, tuberculosis (What is tuberculosis?). Inipomp dosage: . During the same period patient was treated with PROTELOS (View Protelos Review and Protelos Label ), METOJECT (View Metoject Review and Metoject Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), IXPRIM (View Ixprim Review and Ixprim Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), IPERTEN (10 Mg) (View Iperten Review and Iperten Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6634095-1 | Axonal Neuropathy, Blood Creatine Phosphokinase Increased, Bronchial Disorder, Bronchial Obstruction, Hypogammaglobulinaemia, Inflammation, Lipodystrophy Acquired, Lipomatosis
Patient was taking Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: axonal neuropathy, blood creatine phosphokinase increased, bronchial disorder, bronchial obstruction, hypogammaglobulinaemia, inflammation, lipodystrophy acquired, lipomatosis on Mar 03, 2010 from GERMANY Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with gastric ulcer, hypercholesterolaemia, osteoporosis (What is osteoporosis?), temporal arteritis and. Inipomp dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PROTELOS (View Protelos Review and Protelos Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), PREDNISONE (5 Mg) (View Prednisone Review and Prednisone Label ), DIFFU K (2 Dosage Forms) (View Diffu K Review and Diffu K Label ), VERAPAMIL (2 Dosage Forms) (View Verapamil Review and Verapamil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6556755-3 | Deep Vein Thrombosis, Pleural Effusion, Pulmonary Embolism, Tuberculosis
Adverse event was reported on Jan 18, 2010 by a Female patient taking Inipomp (View Usage) (Dosage: ) . Location: FRANCE , 84 years of age, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pleural effusion, pulmonary embolism (What is pulmonary embolism?), tuberculosis (What is tuberculosis?). During the same period patient was treated with PROTELOS (View Protelos Review and Protelos Label ), METOJECT (View Metoject Review and Metoject Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), IXPRIM (View Ixprim Review and Ixprim Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), IPERTEN (10 Mg) (View Iperten Review and Iperten Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6509648-1 | Agranulocytosis, Septic Shock
on Dec 16, 2009 Female patient from GERMANY , 74 years of age, was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: agranulocytosis, septic shock. Inipomp dosage: . During the same period patient was treated with FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), PREVISCAN (View Previscan Review and Previscan Label ), FOSFOMYCIN (View Fosfomycin Review and Fosfomycin Label ), LYRICA (View Lyrica Review and Lyrica Label ), STABLON (View Stablon Review and Stablon Label ).

6453346-X | Eosinophilia, Infection, Inflammation, Urticaria
on Nov 12, 2009 Male patient from FRANCE , 67 years of age, was diagnosed with duodenal ulcer and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, infection (What is infection?), inflammation, urticaria. Inipomp dosage: . During the same period patient was treated with BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), CRESTOR (View Crestor Review and Crestor Label ), NEXIUM (View Nexium Review and Nexium Label ), SOLUPRED (View Solupred Review and Solupred Label ). Patient was hospitalized.

6409705-4 | Cholestasis, Hepatitis Cholestatic, Jaundice, Lymphocytic Infiltration, Pruritus
Patient was taking Inipomp (View Usage). Patient had the following side effects: cholestasis, hepatitis cholestatic, jaundice (What is jaundice?), lymphocytic infiltration, pruritus on Oct 08, 2009 from FRANCE Additional patient health information: Female patient , 39 years of age, was diagnosed with nausea (What is nausea?), abdominal pain upper and. Inipomp dosage: 20 Mg/day. During the same period patient was treated with DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ), COLTRAMYL (Unk) (View Coltramyl Review and Coltramyl Label ), IXPRIM (Unk) (View Ixprim Review and Ixprim Label ). Patient was hospitalized.

6327584-0 | Hyponatraemia
Adverse event was reported on Jan 05, 2009 by a Male patient taking Inipomp (View Usage) (Dosage: 20 Mg, Exact Daily Dose Not Reported) was diagnosed with hypertension and. Location: FRANCE , 85 years of age, After Inipomp was administered, patient had the following side effects: hyponatraemia. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6326965-9 | Hyponatraemia
on Aug 13, 2009 Female patient from FRANCE , 68 years of age, was diagnosed with hypertension, diabetes mellitus, ischaemic stroke and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Inipomp dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6130111-4 | Condition Aggravated, Diabetes Mellitus, Haemoglobin Decreased, Hypotension, Immunoglobulins Increased, Leukopenia, Multi-organ Failure, Oxygen Saturation Decreased, Platelet Count Decreased
on Mar 12, 2009 Male patient from FRANCE , 71 years of age, was diagnosed with eschar and was treated with Inipomp (View Usage). Patient had the following side effects: condition aggravated, diabetes mellitus, haemoglobin decreased, hypotension, immunoglobulins increased, leukopenia, multi-organ failure, oxygen saturation decreased, platelet count decreased. Inipomp dosage: . During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), EQUANIL (View Equanil Review and Equanil Label ). Patient was hospitalized.

6085122-4 | Basal Cell Carcinoma, Dermatitis Exfoliative, Hyperkeratosis, Insomnia, Pruritus, Rash Maculo-papular
Patient was taking Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: basal cell carcinoma, dermatitis exfoliative, hyperkeratosis, insomnia, pruritus, rash maculo-papular on Feb 11, 2009 from GERMANY Additional patient health information: Female patient , 71 years of age, . Inipomp dosage: Unk. During the same period patient was treated with MONO TILDIEM (Unk) (View Mono-tildiem Review and Mono-tildiem Label ), VOLTARENE (Unk) (View Voltarene Review and Voltarene Label ), ALDALIX (Unk) (View Aldalix Review and Aldalix Label ), DOMPERIDONE (Unk) (View Domperidone Review and Domperidone Label ), PRAVASTATIN (Unk) (View Pravastatin Review and Pravastatin Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), STABLON (View Stablon Review and Stablon Label ). Patient was hospitalized.

6083617-0 | Dermatitis Exfoliative, Purpura, Rash Macular
Adverse event was reported on Feb 11, 2009 by a Female patient taking Inipomp (View Usage) (Dosage: ) was diagnosed with pyrexia and. Location: GERMANY , 72 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, purpura, rash macular. During the same period patient was treated with RISORDAN (View Risordan Review and Risordan Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6082466-7 | Dermatitis Exfoliative
on Feb 06, 2009 Female patient from GERMANY , 71 years of age, was treated with Inipomp (View Usage). Patient had the following side effects: dermatitis exfoliative. Inipomp dosage: . During the same period patient was treated with VOLTARENE (View Voltarene Review and Voltarene Label ), STABLON (View Stablon Review and Stablon Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), PRAVASTATINE ^SQUIBB^ (View Pravastatine ^squibb^ Review and Pravastatine ^squibb^ Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), MONO TILDIEM (View Mono-tildiem Review and Mono-tildiem Label ), ALDALIX (View Aldalix Review and Aldalix Label ). Patient was hospitalized.

6070062-7 | Cholestasis, Erythema, Nikolsky's Sign, Pain, Skin Lesion, Stupor, Toxic Epidermal Necrolysis
on Feb 04, 2009 Female patient from GERMANY , weighting 163.1 lb, was diagnosed with hyperuricaemia and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: cholestasis, erythema, nikolsky's sign, pain (What is pain?), skin lesion, stupor, toxic epidermal necrolysis. Inipomp dosage: 20 Mg, 1 In 1 D. During the same period patient was treated with CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ), ZYLORIC (Unk) (View Zyloric Review and Zyloric Label ), TREOSULFAN (21 G, Unk) (View Treosulfan Review and Treosulfan Label ), FLUDARA (52 Mg, Unk) (View Fludara Review and Fludara Label ), FASTURTEC (15 Mg, Unk) (View Fasturtec Review and Fasturtec Label ).

6065435-2 | Agranulocytosis, Asthenia, Inflammation, Renal Failure
Patient was taking Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, asthenia, inflammation, renal failure on Jan 23, 2009 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), atrial flutter, angina pectoris, cardiac failure, essential hypertension and. Inipomp dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), TRINITRIN (View Trinitrin Review and Trinitrin Label ), LASILIX (View Lasilix Review and Lasilix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

6063965-0 | Cholestasis, Erythema, Nikolsky's Sign, Pain, Skin Lesion, Stupor, Toxic Epidermal Necrolysis
Adverse event was reported on Jan 30, 2009 by a Female patient taking Inipomp (View Usage) (Dosage: 20 Mg, 1 In 1 D) was diagnosed with hyperuricaemia, klebsiella infection and. Location: GERMANY , weighting 163.1 lb, Patient had the following side effects: cholestasis, erythema, nikolsky's sign, pain (What is pain?), skin lesion, stupor, toxic epidermal necrolysis. During the same period patient was treated with ZYLORIC (Unk) (View Zyloric Review and Zyloric Label ), TREOSULFAN (21 G, Unk) (View Treosulfan Review and Treosulfan Label ), FLUDARA (52 Mg, Unk) (View Fludara Review and Fludara Label ), FASTURTEC (15 Mg, Unk) (View Fasturtec Review and Fasturtec Label ), TAZOCILLINE (12 G, Unk) (View Tazocilline Review and Tazocilline Label ), CIFLOX (Unk) (View Ciflox Review and Ciflox Label ), METHOTREXATE (26 Mg) (View Methotrexate Review and Methotrexate Label ).

6062819-3 | Dermatitis Exfoliative, Purpura, Rash Macular
on Jan 23, 2009 Female patient from GERMANY , 72 years of age, was diagnosed with pyrexia and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: dermatitis exfoliative, purpura, rash macular. Inipomp dosage: . During the same period patient was treated with RISORDAN (View Risordan Review and Risordan Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), CLAMOXYL (Unnknown) (View Clamoxyl Review and Clamoxyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6061679-4 | Mouth Haemorrhage, Oropharyngeal Blistering, Thrombocytopenic Purpura
on Jan 21, 2009 Male patient from FRANCE , 52 years of age, was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: mouth haemorrhage, oropharyngeal blistering, thrombocytopenic purpura. Inipomp dosage: . During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), KEPPRA (View Keppra Review and Keppra Label ), LASILIX (View Lasilix Review and Lasilix Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), RENAGEL (View Renagel Review and Renagel Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), ZOPHREN (View Zophren Review and Zophren Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ). Patient was hospitalized.

6038938-4 | Hyponatraemia
Patient was taking Inipomp (View Usage). Patient had the following side effects: hyponatraemia on Jan 06, 2009 from FRANCE Additional patient health information: Female patient , 74 years of age, . Inipomp dosage: . During the same period patient was treated with TAREG (View Tareg Review and Tareg Label ). Patient was hospitalized.

6032321-3 | Agranulocytosis, Pyrexia
Adverse event was reported on Dec 29, 2008 by a Male patient taking Inipomp (View Usage) (Dosage: ) . Location: GERMANY , 45 years of age, After Inipomp was administered, patient had the following side effects: agranulocytosis, pyrexia. During the same period patient was treated with INDOCIN (View Indocin Review and Indocin Label ). Patient was hospitalized.

5943620-5 | Aspiration Bronchial, Aspiration Tracheal, Bezoar, Constipation, Gastrointestinal Haemorrhage, Respiratory Distress
on Oct 29, 2008 Female patient from FRANCE , 79 years of age, was diagnosed with gastric haemorrhage, constipation (What is constipation?), pruritus and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration bronchial, aspiration tracheal, bezoar, constipation (What is constipation?), gastrointestinal haemorrhage, respiratory distress. Inipomp dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), CHOLESTYRAMINE (View Cholestyramine Review and Cholestyramine Label ), OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ). Patient was hospitalized.

5901570-4 | Hyponatraemia
on Sep 17, 2008 Female patient from FRANCE , 74 years of age, was treated with Inipomp (View Usage). Patient had the following side effects: hyponatraemia. Inipomp dosage: . During the same period patient was treated with TAREG (View Tareg Review and Tareg Label ). Patient was hospitalized.

5884163-7 | Nephritis Interstitial, Renal Failure Acute, Respiratory Disorder
Patient was taking Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: nephritis interstitial, renal failure acute, respiratory disorder on Sep 03, 2008 from FRANCE Additional patient health information: Female patient , 77 years of age, was diagnosed with prophylaxis, arthralgia and. Inipomp dosage: . During the same period patient was treated with CARTREX (View Cartrex Review and Cartrex Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ). Patient was hospitalized.

5870729-7 | Bezoar
Adverse event was reported on Aug 25, 2008 by a Female patient taking Inipomp (View Usage) (Dosage: 100 Mg Administered Continuously Over 24 Hours) was diagnosed with gastric haemorrhage, constipation (What is constipation?), pruritus and. Location: FRANCE , 79 years of age, Patient experienced the following unwanted or unexpected effects: bezoar. During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), COLESTYRAMINE (View Colestyramine Review and Colestyramine Label ). Patient was hospitalized.

5840776-X | Bezoar
on Jul 30, 2008 Female patient from FRANCE , 79 years of age, was diagnosed with gastric haemorrhage, pruritus and was treated with Inipomp (View Usage). Patient had the following side effects: bezoar. Inipomp dosage: . During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), COLESTYRAMINE (View Colestyramine Review and Colestyramine Label ). Patient was hospitalized.

5837196-0 | Lichen Planus
on Jul 30, 2008 Female patient from FRANCE , 78 years of age, was diagnosed with abdominal pain upper, bronchitis chronic, osteoporosis (What is osteoporosis?), hypertension and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: lichen planus. Inipomp dosage: . During the same period patient was treated with SOLUPRED (View Solupred Review and Solupred Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5818760-1 | Gastric Polyps
Patient was taking Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: gastric polyps on Jul 11, 2008 from FRANCE Additional patient health information: Female patient , 64 years of age, was diagnosed with gastrooesophageal reflux disease, oesophagitis and. Inipomp dosage: .

5813864-1 | Hyponatraemia
Adverse event was reported on Jul 09, 2008 by a Female patient taking Inipomp (View Usage) (Dosage: ) was diagnosed with abdominal pain upper, back pain (What is back pain?), oedema and. Location: FRANCE , 93 years of age, Patient had the following side effects: hyponatraemia. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LASIX (View Lasix Review and Lasix Label ).

5811400-7 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Jul 07, 2008 Female patient from FRANCE , 86 years of age, was diagnosed with oesophagitis, hypothyroidism and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Inipomp dosage: . During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), FUMAFER (View Fumafer Review and Fumafer Label ), VASTAREL (View Vastarel Review and Vastarel Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), FORLAX (View Forlax Review and Forlax Label ), NEXIUM (View Nexium Review and Nexium Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

5809432-8 | Anorexia, Asthenia, Blood Chloride Decreased, Confusional State, Depression, Fall, Hyponatraemia, Nausea
on Jul 03, 2008 Female patient from GERMANY , 83 years of age, was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, blood chloride decreased, confusional state, depression (What is depression?), fall (What is fall?), hyponatraemia, nausea (What is nausea?). Inipomp dosage: . During the same period patient was treated with ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), PRITOR (View Pritor Review and Pritor Label ), ACTONEL (View Actonel Review and Actonel Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ), INNOHEP (View Innohep Review and Innohep Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ). Patient was hospitalized.

5700858-X | Agranulocytosis, Febrile Neutropenia
Patient was taking Inipomp (View Usage). Patient had the following side effects: agranulocytosis, febrile neutropenia on Apr 04, 2008 from GERMANY Additional patient health information: Female patient , 86 years of age, was diagnosed with endocarditis (What is endocarditis?), pain (What is pain?), arrhythmia (What is arrhythmia?), arthritis infective and. Inipomp dosage: ^1 Df^. During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), DI ANTALVIC (^df^) (View Di-antalvic Review and Di-antalvic Label ), PREVISCAN (View Previscan Review and Previscan Label ), LASILIX (^df^) (View Lasilix Review and Lasilix Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

5612714-6 | Agranulocytosis, Febrile Neutropenia
Adverse event was reported on Jan 24, 2008 by a Female patient taking Inipomp (View Usage) (Dosage: ^1 Df^) was diagnosed with endocarditis (What is endocarditis?), pain (What is pain?), arrhythmia (What is arrhythmia?), arthritis infective and. Location: GERMANY , 86 years of age, After Inipomp was administered, patient had the following side effects: agranulocytosis, febrile neutropenia. During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), DI ANTALVIC (^df^) (View Di-antalvic Review and Di-antalvic Label ), PREVISCAN (View Previscan Review and Previscan Label ), LASILIX (^df^) (View Lasilix Review and Lasilix Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

5611057-4 | Cholestasis
on Jan 21, 2008 Male patient from GERMANY , 73 years of age, was diagnosed with back pain (What is back pain?), sciatica (What is sciatica?), essential hypertension and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis. Inipomp dosage: . During the same period patient was treated with MIOREL (4 Mg (frequency Unspeicified)) (View Miorel Review and Miorel Label ), DI ANTALVIC (^df^) (View Di-antalvic Review and Di-antalvic Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), BREXIN ^EURO LABOR^ (^df^) (View Brexin ^euro-labor^ Review and Brexin ^euro-labor^ Label ), BREXIN ^EURO LABOR^ (View Brexin ^euro-labor^ Review and Brexin ^euro-labor^ Label ). Patient was hospitalized.

5597151-5 | Thrombocytopenia
on Jan 07, 2008 Male patient from GERMANY , 43 years of age, was diagnosed with peptic ulcer (What is peptic ulcer?), renal transplant, lung infection and was treated with Inipomp (View Usage). Patient had the following side effects: thrombocytopenia. Inipomp dosage: . During the same period patient was treated with PROGRAF (^df^) (View Prograf Review and Prograf Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), CIPROFLOXACIN HCL (^df^) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), NEXIUM (^df^) (View Nexium Review and Nexium Label ), MABTHERA (View Mabthera Review and Mabthera Label ), CELLCEPT (View Cellcept Review and Cellcept Label ). Patient was hospitalized.

5566457-8 | Cholelithiasis, Cholestasis
Patient was taking Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: cholelithiasis, cholestasis on Dec 13, 2007 from GERMANY Additional patient health information: Female patient , 79 years of age, . Inipomp dosage: ^df^. During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), MONO TILDIEM (^df^) (View Mono-tildiem Review and Mono-tildiem Label ), DI ANTALVIC (^df^) (View Di-antalvic Review and Di-antalvic Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ), AMARYL (^df^) (View Amaryl Review and Amaryl Label ), PAROXETINE HCL (^df^) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DIFFU K (View Diffu K Review and Diffu K Label ), GLYCERYL TRINITRATE (^df^) (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ). Patient was hospitalized.

5535915-4 | Inappropriate Antidiuretic Hormone Secretion
Adverse event was reported on Nov 26, 2007 by a Female patient taking Inipomp (View Usage) (Dosage: ) was diagnosed with gastric ulcer and. Location: GERMANY , 72 years of age, Patient experienced the following unwanted or unexpected effects: inappropriate antidiuretic hormone secretion. Patient was hospitalized.

5498648-9 | Renal Failure Acute
on Oct 19, 2007 Male patient from FRANCE , 53 years of age, was diagnosed with essential hypertension, dental discomfort and was treated with Inipomp (View Usage). Patient had the following side effects: renal failure acute. Inipomp dosage: . During the same period patient was treated with DETENSIEL (View Detensiel Review and Detensiel Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ). Patient was hospitalized.

5488258-1 | Anaphylactic Shock, Arthritis Allergic, Arthritis Infective, Condition Aggravated, Musculoskeletal Pain
on Oct 05, 2007 Male patient from GERMANY , 62 years of age, was diagnosed with gastric haemorrhage and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: anaphylactic shock, arthritis allergic, arthritis infective, condition aggravated, musculoskeletal pain. Inipomp dosage: . During the same period patient was treated with PLAVIX (Dose Form) (View Plavix Review and Plavix Label ), PRAVASTATIN (Dose Form) (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

5447470-8 | Subcutaneous Haematoma, Thrombocytopenia
Patient was taking Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: subcutaneous haematoma, thrombocytopenia on Sep 05, 2007 from FRANCE Additional patient health information: Female patient , 59 years of age, . Inipomp dosage: ^df^. During the same period patient was treated with LEVOTHYROX (^df^) (View Levothyrox Review and Levothyrox Label ), ATACAND (^df^) (View Atacand Review and Atacand Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5447423-X | Aphasia, Blood Calcium Increased, Diabetic Hyperosmolar Coma, Type 1 Diabetes Mellitus
Adverse event was reported on Aug 29, 2007 by a Female patient taking Inipomp (View Usage) (Dosage: ) was diagnosed with osteoporosis (What is osteoporosis?), cardiac failure and. Location: FRANCE , 93 years of age, Patient had the following side effects: aphasia (What is aphasia?), blood calcium increased, diabetic hyperosmolar coma, type 1 diabetes mellitus. During the same period patient was treated with STILNOX (^df^) (View Stilnox Review and Stilnox Label ), STRONTIUM RANELATE (^df^) (View Strontium Ranelate Review and Strontium Ranelate Label ), SERC ^DUPHAR^ (^df^) (View Serc ^duphar^ Review and Serc ^duphar^ Label ), CELECTOL (^df^) (View Celectol Review and Celectol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LASIX (^df^) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5447423-X | Aphasia, Blood Calcium Increased, Diabetic Hyperosmolar Coma, Type 1 Diabetes Mellitus
on Aug 29, 2007 Female patient from FRANCE , 93 years of age, was diagnosed with osteoporosis (What is osteoporosis?), cardiac failure and was treated with Inipomp (View Usage). After Inipomp was administered, patient had the following side effects: aphasia (What is aphasia?), blood calcium increased, diabetic hyperosmolar coma, type 1 diabetes mellitus. Inipomp dosage: . During the same period patient was treated with STILNOX (^df^) (View Stilnox Review and Stilnox Label ), STRONTIUM RANELATE (^df^) (View Strontium Ranelate Review and Strontium Ranelate Label ), SERC ^DUPHAR^ (^df^) (View Serc ^duphar^ Review and Serc ^duphar^ Label ), CELECTOL (^df^) (View Celectol Review and Celectol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LASIX (^df^) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5431665-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Sodium Decreased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, Serum Ferritin Increased, Toxic Epidermal Necrolysis
on Aug 22, 2007 Female patient from FRANCE , 76 years of age, was diagnosed with gastrooesophageal reflux disease, depression (What is depression?), urinary tract infection (What is urinary tract infection?), urinary tract disorder and was treated with Inipomp (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood sodium decreased, c-reactive protein increased, gamma-glutamyltransferase increased, serum ferritin increased, toxic epidermal necrolysis. Inipomp dosage: . During the same period patient was treated with ESCITALOPRAM OXALATE (1/day 1 Df) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), SIMVASTATIN (1/day 40 Mg) (View Simvastatin Review and Simvastatin Label ), INDAPAMIDE (1/day 1.5 Mg) (View Indapamide Review and Indapamide Label ), TRIATEC (1/day 5 Mg) (View Triatec Review and Triatec Label ), HYPERIUM (1/day 1 Df) (View Hyperium Review and Hyperium Label ), BACTRIM DS (Df) (View Bactrim Ds Review and Bactrim Ds Label ), OROKEN (1/day 1 Df) (View Oroken Review and Oroken Label ). Patient was hospitalized.

5429615-9 | Subcutaneous Haematoma, Thrombocytopenia
Patient was taking Inipomp (View Usage). Patient had the following side effects: subcutaneous haematoma, thrombocytopenia on Aug 17, 2007 from FRANCE Additional patient health information: Female patient , 59 years of age, . Inipomp dosage: ^df^. During the same period patient was treated with LEVOTHYROXINE SODIUM (^df^) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATACAND (^df^) (View Atacand Review and Atacand Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.